Gates Industrial (GTES) is a Great Momentum Stock: Should You Buy? — Positive

GTES   Zacks Investment Research — July 17, 2025

Does Gates Industrial (GTES) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Gates Industrial (GTES) is a Great Momentum Stock: Should You Buy?

PROKIDNEY CP (PROK) Upgraded to Strong Buy: What Does It Mean for the Stock? — Positive

PROK   Zacks Investment Research — July 17, 2025

PROKIDNEY CP (PROK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

image for news PROKIDNEY CP (PROK) Upgraded to Strong Buy: What Does It Mean for the Stock?

Are You Looking for a Top Momentum Pick? Why GE Aerospace (GE) is a Great Choice — Positive

GE   Zacks Investment Research — July 17, 2025

Does GE Aerospace (GE) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Are You Looking for a Top Momentum Pick? Why GE Aerospace (GE) is a Great Choice

PepsiCo reported better-than-expected earnings and revenue in the second quarter despite sluggish North American sales.Sales of Frito-Lay and other snacks fell 1% in North America during the April-June period, PepsiCo said Thursday, while beverage sales were down 2% in the region. But sales rose in some other regions, including Latin America and Asia.Revenue rose less than 1% to $22.7 billion in the April-June period.

image for news PepsiCo's Q2 earnings beat Wall Street expectations despite sluggish U.S. sales

What Makes Northwest Natural (NWN) a New Strong Buy Stock — Positive

NWN   Zacks Investment Research — July 17, 2025

Northwest Natural (NWN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news What Makes Northwest Natural (NWN) a New Strong Buy Stock

Fortuna (FSM) Upgraded to Buy: Here's Why — Positive

FSM   Zacks Investment Research — July 17, 2025

Fortuna (FSM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news Fortuna (FSM) Upgraded to Buy: Here's Why

Monarch Casino (MCRI) Upgraded to Buy: What Does It Mean for the Stock? — Positive

MCRI   Zacks Investment Research — July 17, 2025

Monarch Casino (MCRI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Monarch Casino (MCRI) Upgraded to Buy: What Does It Mean for the Stock?

All You Need to Know About Central Garden (CENTA) Rating Upgrade to Strong Buy — Positive

CENTA   Zacks Investment Research — July 17, 2025

Central Garden (CENTA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news All You Need to Know About Central Garden (CENTA) Rating Upgrade to Strong Buy

Silvercorp (SVM) Is Up 10.34% in One Week: What You Should Know — Positive

SVM   Zacks Investment Research — July 17, 2025

Does Silvercorp (SVM) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Silvercorp (SVM) Is Up 10.34% in One Week: What You Should Know

Announcement comes after Gov. Sanders, AEDC met with L3Harris at Paris Air Show Announcement comes after Gov. Sanders, AEDC met with L3Harris at Paris Air Show

image for news L3Harris to Build More than 20 New Large Solid Rocket Motor Manufacturing Facilities in Calhoun County, Arkansas

Despite new market entrants in the form of Gilead's Livdelzi and Ipsen's Iqirvo, US gastroenterologists report nearly half of PBC patients suffer from moderate to severe pruritus, underscoring an existing unmet need. Despite new market entrants in the form of Gilead's Livdelzi and Ipsen's Iqirvo, US gastroenterologists report nearly half of PBC patients suffer from moderate to severe pruritus, underscoring an existing unmet need.

image for news GSK's Linerixibat Poised to Address Substantial Unmet Need for the Treatment of Pruritus Associated with Primary Biliary Cholangitis, According to Spherix Global Insights

Duolingo Set For Q2 Bookings Beat, Guidance Likely Conservative — Positive

DUOL   Benzinga — July 17, 2025

Duolingo shares have tumbled 24% in the past month amid concerns over slowing growth and rising churn, despite strong global brand momentum.

image for news Duolingo Set For Q2 Bookings Beat, Guidance Likely Conservative

I upgrade FITB to neutral as credit risk has stabilized and national loan loss trends have improved, reducing immediate downside risk. Deposit declines and overreliance on low-cost, non-sticky funding threaten FITB's net interest margin if rates don't fall as much as management hopes. FITB's valuation remains high at 2.2x tangible book, leaving little margin for error if net interest income growth slows or credit costs rise.

image for news Fifth Third: Q2 Report Shows Net Interest Income Growth Sacrifices Deposits

Marsh & McLennan Q2 Earnings Beat on Risk and Insurance Strength — Positive

MMC   Zacks Investment Research — July 17, 2025

MMC posts strong Q2 with EPS up 11% and revenues up 12%, fueled by robust growth in Risk and Insurance Services.

image for news Marsh & McLennan Q2 Earnings Beat on Risk and Insurance Strength

NEW YORK--(BUSINESS WIRE)---- $RXST #Attorney--Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into RxSight, Inc. (NASDAQ: RXST) for potential violations of the federal securities laws. If you invested in RxSight, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/rxsight-inc-class-action-lawsuit. Why is RxSight being Investigated? RxSight is engaged in the manufacture and sale of light adjustable intraocular lenses use.

image for news RXST BREAKING NEWS: BFA Law is Investigating RxSight, Inc. for Securities Fraud; Contact the Firm about how to Potentially Recover Investment Losses

A 6% Pop Can't Fix PepsiCo's Bigger Problems — Negative

PEP   Seeking Alpha — July 17, 2025

Despite a Q2 earnings beat, PepsiCo's core issues—weak volume trends, dividend strain, and overreliance on pricing—remain unresolved and have worsened. Total return for PepsiCo over the last three years is negative, even with dividends, underperforming peers like Coca-Cola and Monster Beverage. A $1.9 billion impairment charge and high debt levels highlight ongoing concerns about PepsiCo's growth strategy and rich valuation.

image for news A 6% Pop Can't Fix PepsiCo's Bigger Problems

Fifth Third Bancorp (FITB) Q2 2025 Earnings Call Transcript — Neutral

FITB   Seeking Alpha — July 17, 2025

Fifth Third Bancorp (NASDAQ:FITB ) Q2 2025 Earnings Conference Call July 17, 2025 9:00 AM ET Company Participants Bryan D. Preston - Executive VP & CFO Greg Schroeck - Corporate Participant Matt Curoe - Corporate Participant Timothy N.

image for news Fifth Third Bancorp (FITB) Q2 2025 Earnings Call Transcript

DRAM Demand Powers Micron Technology's Growth: Will the Momentum Last? — Positive

MU   Zacks Investment Research — July 17, 2025

AI, auto, and mobile markets powered MU's DRAM sales up 51% in Q3, with FY25 revenue set for nearly 59% growth.

image for news DRAM Demand Powers Micron Technology's Growth: Will the Momentum Last?

SMR Benefits From Expanding Partner Base: A Sign for More Upside? — Positive

SMR   Zacks Investment Research — July 17, 2025

NuScale Power is gaining traction as tech giants adopt its nuclear tech, but rising competition and valuation may test its momentum.

image for news SMR Benefits From Expanding Partner Base: A Sign for More Upside?

FSTA: Consumer Staples Dashboard For July — Positive

FSTA   Seeking Alpha — July 17, 2025

This article provides a top-down analysis of the consumer staples sector based on valuation, quality, and momentum metrics. Food, beverage, and household products industries are undervalued, while tobacco industry is notably overvalued and has the lowest quality score. FSTA ETF is a solid long-term equivalent to XLP, but XLP is preferable for trading, while RSPS offers lower concentration risk.

image for news FSTA: Consumer Staples Dashboard For July